Prognostic Value of the Pretreatment Advanced Lung Cancer Inflammation Index (ALI) in Diffuse Large B Cell Lymphoma Patients Treated with R-CHOP Chemotherapy

Publisher： Karger

E-ISSN： 1421-9662|137|2|76-85

ISSN： 0001-5792

Source： Acta Haematologica, Vol.137, Iss.2, 2017-01, pp. : 76-85

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Multiplex polymerase chain reaction‐based prognostic models in diffuse large B‐cell lymphoma patients treated with R‐CHOP

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 174, Iss. 6, 2016-09 ,pp. : 876-886

John Wiley & Sons Inc

Access to resources Recommend Favorite

Deliverability and efficacy of R‐CHOP chemotherapy in very elderly patients with diffuse large B‐cell lymphoma: an Australian retrospective analysis

By  

INTERNAL MEDICINE JOURNAL, Vol. 45, Iss. 11, 2015-11 ,pp. : 1147-1153

John Wiley & Sons Inc

Access to resources Recommend Favorite

Weekly rituximab consolidation following four cycles of R‐CHOP induction chemotherapy in very elderly patients with diffuse large B‐cell lymphoma: Consortium for improving survival of lymphoma study (CISL)

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 94, Iss. 6, 2015-06 ,pp. : 504-510

John Wiley & Sons Inc

Access to resources Recommend Favorite

Dose-Dense CHOP plus Rituximab (R-CHOP14) for the Treatment of Elderly Patients with High-Risk Diffuse Large B Cell Lymphoma: A Pilot Study

By  

Acta Haematologica, Vol. 115, Iss. 1-2, 2006-01 ,pp. : 22-27

Karger

Access to resources Recommend Favorite

Prognostic value of complete remission status at end‐of‐treatment FDG‐PET in R‐CHOP‐treated diffuse large B‐cell lymphoma: systematic review and meta‐analysis

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 170, Iss. 2, 2015-07 ,pp. : 185-191

John Wiley & Sons Inc

Access to resources Recommend Favorite